Your opponent's Active Pokémon is now Poisoned.
Collector-focused market read: Short-term movement is stable (0.0% over 7 days), with price action clustered near recent averages. With a 50% 90-day spread ($0.03-$0.06), this card currently tracks as high-volatility.
Versus the 30-day average ($0.06), the card is trading 3.4% higher. The clearest graded reference is PSA 9 at $14.99, or +24883% relative to raw.
Toxicroak from Paldea Evolved is currently trading around $0.06. Its 7-day movement is largely flat at 0.0%.
Current value is elevated versus the 30-day mean ($0.06), by 3.4%. The 90-day window shows a floor near $0.03 and a peak around $0.06 (50% total spread), which maps to high-volatility movement.
The listed rarity for this print is Uncommon.
In 2023, Paldea Evolved introduced this print of Toxicroak. The printed flavor text states: "Swaying and dodging the attacks of its foes, it weaves its flexible body in close, then lunges out with its poisonous claws." Its card type is Pokémon.
The rarity label is Uncommon. Printed HP is 130.
Energy typing is Fighting. This card evolves from Croagunk.
Attack line includes "Pierce" and "Knuckle Claws". It is weak to Psychic type energy.
Paldea Evolved entered circulation in 2023. It belongs to the Scarlet & Violet series.
The checklist contains 279 cards, placing it in a very large expansion range. As of 2026, the set is 3 years old and sits in a modern-era collecting window.
Within this set, Toxicroak is card number 115 with a Uncommon designation.
Collectors tracking Toxicroak often benchmark it against other Toxicroak cards. Comparable entries in this snapshot: 6 cards, 6 distinct sets.
Comparable prices currently cover $0.04-$0.65, a 1525% band. Against the sample mean of $0.23, this card is -74%.
Notable alternatives include Toxicroak #59 (Steam Siege) at $0.23, Toxicroak #166 (Fusion Strike) at $0.12, Toxicroak #110 (Silver Tempest) at $0.07, and Toxicroak #124 (Sword & Shield) at $0.65.
